Avenue Therapeutics, Inc. (ATXI): Price and Financial Metrics
ATXI Price/Volume Stats
| Current price | $2.01 | 52-week high | $26.47 |
| Prev. close | $1.97 | 52-week low | $1.60 |
| Day low | $1.95 | Volume | 19,300 |
| Day high | $2.05 | Avg. volume | 60,078 |
| 50-day MA | $2.24 | Dividend yield | N/A |
| 200-day MA | $5.23 | Market Cap | 3.84M |
ATXI Stock Price Chart Interactive Chart >
Avenue Therapeutics, Inc. (ATXI) Company Bio
Avenue Therapeutics, Inc., a specialty pharmaceutical company, acquires, licenses, develops, and commercializes an intravenous formulation of tramadol HCI principally for use in the acute/intensive care hospital setting. Its product candidate is IV Tramadol for the treatment of post-operative pain. The company was founded in 2015 and is based in New York, New York.
ATXI Price Returns
| 1-mo | -4.74% |
| 3-mo | -31.86% |
| 6-mo | -44.48% |
| 1-year | -85.51% |
| 3-year | -99.85% |
| 5-year | -99.97% |
| YTD | -83.35% |
| 2023 | -86.12% |
| 2022 | -91.48% |
| 2021 | -84.74% |
| 2020 | -38.02% |
| 2019 | 77.78% |
Loading social stream, please wait...